1. Home
  2. GIII vs NVAX Comparison

GIII vs NVAX Comparison

Compare GIII & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo G-III Apparel Group LTD.

GIII

G-III Apparel Group LTD.

HOLD

Current Price

$36.36

Market Cap

1.5B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$7.44

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIII
NVAX
Founded
1956
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
2006
1996

Fundamental Metrics

Financial Performance
Metric
GIII
NVAX
Price
$36.36
$7.44
Analyst Decision
Hold
Hold
Analyst Count
5
9
Target Price
$29.00
$11.33
AVG Volume (30 Days)
402.1K
3.1M
Earning Date
06-05-2026
05-06-2026
Dividend Yield
1.29%
N/A
EPS Growth
N/A
309.76
EPS
1.50
N/A
Revenue
$2,957,012,000.00
$1,123,479,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.27
N/A
Revenue Growth
N/A
64.69
52 Week Low
$23.95
$6.20
52 Week High
$37.00
$11.85

Technical Indicators

Market Signals
Indicator
GIII
NVAX
Relative Strength Index (RSI) 58.71 33.78
Support Level $34.07 $6.28
Resistance Level $36.43 $10.10
Average True Range (ATR) 0.91 0.30
MACD 0.06 -0.05
Stochastic Oscillator 62.27 22.59

Price Performance

Historical Comparison
GIII
NVAX

About GIII G-III Apparel Group LTD.

G-III Apparel Group Ltd is an apparel manufacturing company. The company makes a wide range of apparel, footwear, and accessories that sells under its own brands, licensed brands, and private-label brands. It has a substantial portfolio for licensed and proprietary brands, anchored by brands: DKNY, Donna Karan, Karl Lagerfeld, Karl Lagerfeld Paris, Vilebrequin, and others. The reportable segments of the company are Wholesale Operations and Retail Operations. The Wholesale operations segment includes sales of products under brands licensed by from third parties, and sales of products under its own brands and private label brands. The retail operations segment consists of Wilsons Leather, G.H. Bass, and DKNY retail stores. It derives majority of its revenue from Wholesale operations.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: